122 related articles for article (PubMed ID: 23157232)
1. Drug discovery: a view through the looking glass.
Lenhert S; Vellanti FG
Future Med Chem; 2012 Oct; 4(16):2011-3. PubMed ID: 23157232
[No Abstract] [Full Text] [Related]
2. The application of next-generation sequencing technologies to drug discovery and development.
Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
[TBL] [Abstract][Full Text] [Related]
3. The era of cancer discovery.
Cantley LC; Baselga J
Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
[No Abstract] [Full Text] [Related]
4. Reducing the multidimensionality of high-content screening into versatile powerful descriptors.
Gorenstein J; Zack B; Marszalek JR; Bagchi A; Subramaniam S; Carroll P; Elbi C
Biotechniques; 2010 Sep; 49(3):663-5. PubMed ID: 20854269
[TBL] [Abstract][Full Text] [Related]
5. [NMR in the fragment-based drug discovery].
Hanzawa H; Takizawa T
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
[No Abstract] [Full Text] [Related]
6. [Practice of fragment-based lead discovery by X-rays].
Yamano A
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1622-7. PubMed ID: 21089598
[No Abstract] [Full Text] [Related]
7. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
8. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
Hampton SL; Kinnaird AI
Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
[TBL] [Abstract][Full Text] [Related]
9. [Fragment-based lead discovery from smaller fragments to functional ligand].
Hatayama A; Habashita H
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
[No Abstract] [Full Text] [Related]
10. Stem cell themes: promises and challenges.
Glicksman M; Pajak L; Lam K
J Biomol Screen; 2012 Oct; 17(9):E1-3. PubMed ID: 23023569
[No Abstract] [Full Text] [Related]
11. Systems biology in drug discovery and development.
Berg EL
Drug Discov Today; 2014 Feb; 19(2):113-25. PubMed ID: 24120892
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of molecular diversity in drug discovery.
Marcaurelle LA; Foley MA
Curr Opin Chem Biol; 2010 Jun; 14(3):285-8. PubMed ID: 20472491
[No Abstract] [Full Text] [Related]
13. Renaissance of ion channel research and drug discovery by patch clamp automation.
Fertig N; Farre C
Future Med Chem; 2010 May; 2(5):691-5. PubMed ID: 21426196
[No Abstract] [Full Text] [Related]
14. The impact of genetic biomarkers on drug and companion diagnostic return on investment.
Keeling P
Drug Discov Today; 2011 Oct; 16(19-20):850-1. PubMed ID: 21906694
[No Abstract] [Full Text] [Related]
15. [Study on ion channel transporters as a target for the drug discovery].
Imaizumi Y; Kaneko S
Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):227. PubMed ID: 22303567
[No Abstract] [Full Text] [Related]
16. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
17. Concise review: a high-content screening approach to stem cell research and drug discovery.
Xia X; Wong ST
Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
[TBL] [Abstract][Full Text] [Related]
18. Genomics and drug discovery.
Lundstrom K
Future Med Chem; 2011 Nov; 3(15):1855-8. PubMed ID: 22023028
[No Abstract] [Full Text] [Related]
19. Toward molecular imaging-driven drug development in oncology.
de Vries EG; Oude Munnink TH; van Vugt MA; Nagengast WB
Cancer Discov; 2011 Jun; 1(1):25-8. PubMed ID: 22586317
[TBL] [Abstract][Full Text] [Related]
20. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
Seneci P
IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
